Ontrak, Inc. Stock

Equities

OTRK

US6833733024

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 12:58:36 2024-05-24 pm EDT 5-day change 1st Jan Change
0.273 USD +0.37% Intraday chart for Ontrak, Inc. +5.88% -32.67%
Sales 2024 * 11.8M Sales 2025 * 25.66M Capitalization 13.05M
Net income 2024 * -26M Net income 2025 * -18M EV / Sales 2024 * 1.11 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.51 x
P/E ratio 2024 *
-0.68 x
P/E ratio 2025 *
-1.18 x
Employees 103
Yield 2024 *
-
Yield 2025 *
-
Free-Float 39.37%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.49%
1 week-2.47%
Current month-0.73%
1 month-21.43%
3 months+43.01%
6 months-52.28%
Current year-32.17%
More quotes
1 week
0.25
Extreme 0.2543
0.28
1 month
0.22
Extreme 0.2204
0.34
Current year
0.14
Extreme 0.135
1.07
1 year
0.14
Extreme 0.135
4.08
3 years
0.14
Extreme 0.135
249.90
5 years
0.14
Extreme 0.135
599.34
10 years
0.14
Extreme 0.135
599.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 20-03-11
Director of Finance/CFO 47 19-09-30
President 63 21-08-29
Members of the board TitleAgeSince
Director/Board Member 79 14-02-12
Director/Board Member 65 22-08-29
Chairman 65 17-07-13
More insiders
Date Price Change Volume
24-05-24 0.27 -0.74% 139 838
24-05-23 0.272 +1.49% 382,661
24-05-22 0.268 0.00% 131,979
24-05-21 0.268 +3.04% 181,334
24-05-20 0.2601 +2.00% 366,453

Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT

More quotes
Ontrak, Inc. is an artificial intelligence (AI) and telehealth-enabled healthcare company. The Company identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. It engages individuals with anxiety, depression, substance-use disorders and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. Its technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of its personalized care program. The Company integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaches.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.272 USD
Average target price
4 USD
Spread / Average Target
+1,370.59%
Consensus